Retrospective Study
Copyright ©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1441-1449
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1441
Table 1 Comparison of the underlying information, n (%)
Variable
Group 1: Death group (n = 12)
Group 2: Improved group (n = 60)
χ2
P value
Gender:Male11 (91.7)41 (68.3)2.7140.099
History of hypertension3 (25)18 (30)0.1210.728
History of diabetes mellitus3 (25)15 (25)0.0001.000
History of lung disease2 (16.7)4 (6.7)1.3090.253
History of heart disease1 (8.3)7 (11.7)0.1130.737
Chronic kidney disease3 (25)2 (3.3)7.2640.007a
Neurological3 (25)7 (11.7)1.4860.223
History of malignancy2 (16.7)9 (15)0.0210.884
Heavy alcohol consumption7 (58.3)14 (23.3)5.9290.015a
History of hospitalization within 30 days4 (33.3)15 (25)0.3570.550
History of antibiotic exposure within 15 days1 (8.3)6 (10)0.0320.859
Blood glucose > 7.84 (33.3)22 (36.7)0.0480.826